Related Experiment Video

Updated: Nov 30, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.0K

Cardiac Involvement of COVID-19: A Comprehensive Review

Wei-Ting Chang1, Han Siong Toh2, Chia-Te Liao3

  • 1Division of Cardiology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan.

The American Journal of the Medical Sciences
|November 14, 2020
PubMed

Insights

Coronavirus Disease 2019 (COVID-19) significantly impacts the cardiovascular system, increasing risks for patients with existing heart conditions. This review details COVID-19

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, has reached pandemic status.
  • COVID-19 poses significant risks to the cardiovascular system, especially for individuals with pre-existing cardiovascular disease.
  • Mortality in COVID-19 patients is strongly linked to cardiovascular disease, diabetes, and hypertension.

Purpose of the Study:

  • To review the existing literature on the cardiovascular involvement of COVID-19.
  • To understand the direct and indirect cardiovascular complications associated with SARS-CoV-2 infection.
  • To highlight the importance of comprehending COVID-19's cardiovascular effects for patient care.

Main Methods:

  • Literature review of studies on COVID-19 and cardiovascular involvement.
  • Analysis of reported cardiovascular complications and impacts.
  • Synthesis of findings regarding virus-host interactions in the cardiovascular system.

Main Results:

  • COVID-19 patients with pre-existing cardiovascular disease face a higher risk of severe outcomes and death.
  • Investigational COVID-19 therapies may lead to cardiovascular side effects like arrhythmia.
  • SARS-CoV-2 infection can trigger various cardiovascular issues, including vascular inflammation, myocardial injury, myocarditis, arrhythmias, thromboembolism, and Kawasaki disease.

Conclusions:

  • Understanding the multifaceted cardiovascular effects of COVID-19 is crucial for effective patient management.
  • Comprehensive medical care for cardiac patients and COVID-19 patients requires awareness of potential cardiac complications.
  • The review underscores the critical link between SARS-CoV-2 infection and cardiovascular health.

Keywords:
CoronavirusCovid-19Myocardial injurySars-cov-2myocarditis

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.5K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

1.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
204
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
326
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
122
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
151
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
89
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
239